![Clearmind Medicine Inc](/common/images/company/N_CMND.png)
Vancouver, Canada, July 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery...
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery...
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery...
Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
Vancouver, Canada, June 20, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -1.73410404624 | 1.73 | 2.3 | 1.573 | 1334025 | 1.97929429 | CS |
4 | 0.3 | 21.4285714286 | 1.4 | 2.3 | 1.21 | 4817341 | 1.69719038 | CS |
12 | 0.51 | 42.8571428571 | 1.19 | 2.3 | 0.9512 | 2947274 | 1.56014694 | CS |
26 | 0.66 | 63.4615384615 | 1.04 | 2.3 | 0.9205 | 1730248 | 1.56143066 | CS |
52 | -11.218 | -86.840068122 | 12.918 | 16.194 | 0.9205 | 1923730 | 3.36257287 | CS |
156 | -160.9 | -98.9544895449 | 162.6 | 183 | 0.9205 | 1428672 | 9.24949317 | CS |
260 | -160.9 | -98.9544895449 | 162.6 | 183 | 0.9205 | 1428672 | 9.24949317 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.